With the rise of omicron came the fall of long-lasting protection from reinfection with the pandemic coronavirus SARS-CoV-2, according to a study published in Nature. Using population-wide data from ...
A new study found that a previous COVID-19 infection offers at least the same level of protection as two doses of high-quality mRNA vaccines, such as Moderna and Pfizer-BioNTech. Additionally, people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback